Company news
Invo Fertility, Inc. (NASDAQ:IVF) news
Invo Fertility, Inc. news releases on 6ix. Latest, Sep 25, 2026: INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
Press releases & updates
INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference
September 25, 2026
INVO Fertility to Participate in H.C. Wainwright's 28th Annual Global Investment Conference
August 28, 2026
INVO Fertility Announces Five Poster Presentations Highlighting Platelet-Rich Plasma Research at the 2026 Midwest Reproductive Symposium International
August 20, 2026
INVO Fertility Reports Second Quarter 2026 Results Highlighting Revenue Growth and Clinic Platform Profitability
August 17, 2026
INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure
June 22, 2026
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q
June 2, 2026
INVO Fertility Announces Fiscal Year 2025 Financial Results
June 1, 2026
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Annual Report on Form 10-K
April 29, 2026
INVO Fertility Announces a 1:5 Reverse Stock Split Effective Pre-Market Opening on March 27, 2026
March 24, 2026
INVO Fertility Announces Availability of Advanced Incubation Technology at its Wisconsin Clinic
March 4, 2026
INVO Fertility’s Wisconsin Clinic Joins Progyny Network
March 2, 2026
INVO Fertility Closes Acquisition of Indiana-Based Fertility Clinic “Family Beginnings”
February 19, 2026
INVO Fertility Announces Patent Issuance for Modified INVOcell® Device
February 11, 2026
INVO Fertility Issues Shareholder Letter Highlighting Strengthened Fundamental Position and Strategic Outlook for Growth
February 4, 2026
INVO Fertility Enters into $7.5 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules
January 29, 2026
INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026
January 13, 2026
INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy
December 30, 2025
INVO Fertility Signs Definitive Purchase Agreement to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
December 17, 2025
INVO Fertility Announces Pricing of $4.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules
December 2, 2025
INVO Fertility Announces Intent to Acquire Indiana-Based Fertility Clinic “Family Beginnings”
November 28, 2025
INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
November 25, 2025
INVO Fertility Announces Third Quarter 2025 Financial Results
November 17, 2025
INVO Fertility Partners with Heidi Health to Bring AI-Powered Tools to INVO’s Wisconsin Fertility Institute
October 27, 2025
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
September 29, 2025
INVO Fertility Announces Second Quarter 2025 Financial Results
August 14, 2025
INVO Fertility Announces a 1:3 Reverse Stock Split Effective Pre-Market Opening on July 21, 2025
July 17, 2025
INVO Fertility Enhances INVOcell Technology with Expanded Awareness, Training, and Improved Pricing
July 9, 2025
INVO Fertility Adds Platelet-Rich Plasma Therapy Capabilities at Wisconsin Fertility Institute
June 30, 2025
INVO Fertility Receives Notice of Allowance for Modified INVOcell Device Patent
June 25, 2025
INVO Fertility Reminds Shareholders to Cast Their Vote for Upcoming Annual Meeting of Shareholders to be held on Wednesday, June 25, 2025 at 12:00 p.m. Eastern Time
June 20, 2025
INVO Fertility Expands Telehealth Capabilities at Its Wisconsin Fertility Institute
June 18, 2025
INVO Fertility’s Wisconsin Clinic Recognized on Newsweek’s List of America’s Best Fertility Clinics for 2025
June 16, 2025
INVO Fertility to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
May 27, 2025
INVO Fertility Announces First Quarter 2025 Financial Results
May 20, 2025
INVO Fertility Announces 2024 Financial Results with 116% Annual Revenue Growth and Further Improvements in Adjusted EBITDA
April 30, 2025
INVO Fertility Confirms New Nasdaq Trading Symbol of “IVF”
April 23, 2025
NAYA Biosciences Announces Strategic Decision to Separate Fertility and Oncology Businesses into Distinct Operations – Company Renamed “INVO Fertility, Inc.”
April 13, 2025
NAYA Announces a 1:12 Reverse Stock Split Effective Pre-Market Opening on March 18, 2025
March 12, 2025
NAYA Biosciences Announces Nomination of New Board Members
February 18, 2025
NAYA Biosciences Announces Pricing of $9.5 Million Public Offering
January 12, 2025
NAYA Biosciences Announces Development of NY-500, a Novel AI-Optimized PD-1 x VEGF Bifunctional Antibody
January 5, 2025
NAYA Biosciences Announces Initiation of Phase 1/2a Clinical Trial for its GPC3-targeted NK Engager Bispecific Antibody in Patients with Hepatocellular Carcinoma
October 23, 2024
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences
October 20, 2024
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA)
October 13, 2024
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
August 13, 2024
INVO Reports Record First Quarter 2024 Financial Results
May 14, 2024
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
April 15, 2024
INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors
January 16, 2024
NAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journal
December 10, 2023
INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
November 27, 2023